Basic info
Industry
biotechnology research
Sectors
Biotechnology
Pharmaceutical
Toxicity testing
Induced Pluripotent Stem Cells (iPSC)
Inherited Metabolic Diseases (IMD)
Drug Discovery
Hepatocytes
Health Care
Disease Modelling
Pancreatic Cells
Date founded
2012
Funding rounds raised
Total raised
$4.4M
from 8 investors over 8 rounds
D
DefiniGEN raised $4.4M on November 19, 2020
Investors: 24Haymarket
D
DefiniGEN raised $899K on November 1, 2018
Investors: 24Haymarket
D
DefiniGEN raised $2.2M on May 23, 2016
Investors: Cambridge Enterprise, Parkwalk Advisors, Cambridge Angels and 24Haymarket
D
DefiniGEN raised $3.9M on June 2, 2014
Investors: Cambridge Enterprise and 24Haymarket